IsoRay, Inc. announced the publication of a case report in the open access journal Cureus. The paper, entitled 'Excellent Outcomes in a Geriatric Patient with Multiple Brain Metastases Undergoing Surgical Resection with Cesium-131 Implantation and Stereotactic Radiosurgery', represents the most recent publication from the Departments of Neurological Surgery and Radiation Oncology at NewYork-Presbyterian Hospital and Weill Cornell Medical Center. It describes the history of a 90 year old female patient who was first diagnosed with metastatic brain cancer six years previously. Based on several neurological symptoms suffered by the patient, an MRI was undertaken which revealed three metastases in the brain. While there was no definitive evidence of a primary cancer, the physicians considered treating these metastases in order to alleviate the patient's symptoms. While conventional management of such a patient would often involve surgery and whole-brain radiation therapy (WBRT), the WBRT approach has been shown to be associated with a significant risk of negative neurological effects. Although 84 years old at the time, the patient was active and high-functioning and she, her family and her physicians wished to preserve her quality of life and neurological function. On this basis the treating physicians decided to employ surgery and ocal radiation including Cesium-131 brachytherapy and Stereotactic Radiosurgery (SRS). By doing so, the clinical team hoped to offer the patient control of the brain metastases while at the same time sparing her possible neurological side effects. The outcome was very positive, with the patient's brain malignancies quiescent and her neurological function very good six years after diagnosis. This shift in treatment paradigm entails the movement away from complete irradiation of the brain with WBRT and towards focally targeting the cancer with radiosurgery or brachytherapy. Cesium-131 brachytherapy has been reported on several times by the Weill Cornell Medical College and NewYork Presbyterian Hospital with positive outcomes, and may be especially valuable when confronting larger brain metastases.